Open house Arzneimittelrabattverträge Piribedil, ATC N04BC08
Titre original de l'avis
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Piribedil, ATC N04BC08
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
20 / 100
Facteurs de risque
No guaranteed revenue; agreements are discount contracts without purchase obligation.
Open-house model is not subject to procurement law, which may cause legal uncertainty for some bidders.
Submission deadline in 7 days
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Strong opportunityFaits clés
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Non-exclusive discount agreements for the active substance Piribedil (ATC N04BC08) according to §130a Abs. 8 SGB V.
- Contracts are identical and not individually negotiable.
Afficher le résumé complet
Open-house model for non-exclusive discount agreements on Piribedil (ATC N04BC08) with AOK Bayern. Contracts can be concluded at any time until 05.09.2026, with earliest start 01.11.2024 and end 31.10.2026. No selection procedure; all eligible pharmaceutical companies can join. Estimated value not disclosed.
Risques
No guaranteed revenue; agreements are discount contracts without purchase obligation.
Open-house model is not subject to procurement law, which may cause legal uncertainty for some bidders.
Submission deadline in 7 days
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Eligibility
- Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible.
Administrative
- Submission of a signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be submitted.
Les exigences peuvent être incomplètes.
Acheteur
Localisation
München, DEU
Site web
Profil acheteur
Identifiant
DE811695320
Activité
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Piribedil, ATC N04BC08
Non-exclusive discount agreements for Piribedil (ATC N04BC08) with AOK Bayern. Open-house model, no competition, all eligible pharmaceutical firms can participate. Contracts run from 01.11.2024 to 31.10.2026. Submission possible until 05.09.2026.
Localisation
Durée
Catégorie
Date limite
Détails des critères
Siehe kurze Beschreibung
Afficher les données TED originales
Description TED originale
Siehe kurze Beschreibung
Détails de la procédure
- Date de publication
- 16 Sep 2024
- Langues
- German
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 557188-2024
Documents (2)
Appels d'offres similaires
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
20 / 100
Facteurs de risque
No guaranteed revenue; agreements are discount contracts without purchase obligation.
Open-house model is not subject to procurement law, which may cause legal uncertainty for some bidders.
Submission deadline in 7 days
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications